Young Children taking ADHD Drugs May Experience Weight Loss The FDA is revising the labeling of all extended-release stimulants treating attention-deficit/hyperactivity disorder (ADHD) - including certain formulations of amphetamine and methylphenidate - to warn about the risk of weight loss and other adverse reactions (side effects) in patients younger than 6 years taking these medications
the active phytochemicals in milk thistle may also stimulate protein synthesis in liver cells, which helps to regenerate them
Some studies have shown that adipocyte hypertrophy is the primary abdominal SAT phenotype in non-obese men with T2D [47]
Individualized treatment approaches PCOS is a heterogeneous condition with varied presentations and underlying factors
People who have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 should usually stay away from GLP-1 agonists and talk about alternative options with their doctor
It may also mean maintaining strength, protecting muscle, having enough energy for daily life, or creating habits that still feel manageable six months from now